Reliability of the Brazilian version of the functional assessment of cancer therapy-lung (FACT-L) and the FACT-Lung symptom index (FLSI)

Clinics

Volumn 65, Issue 12, 2010, Pages 1247-1251

  Juliana, Franceschini ^a   Jardim, José R ^a   Fernandes, Ana Luisa Godoy ^a   Jamnik, Sérgio ^a   Santoro, Ilka Lopes ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Lung cancer; Quality of life; Questionnaires; Reproducibility of results; Validation studies

Indexed keywords

ARTICLE; BRAZIL; FEMALE; HUMAN; LUNG TUMOR; MALE; MIDDLE AGED; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; STANDARD; VALIDATION STUDY;

BRAZIL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 79951828654     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322010001200005     Document Type: Article

References (32)

1. Landi MT, Consonni D, Rotunno M, Bergen AW, Goldstein AM, Lubin JH, et al. Environment and Genetics in Lung cancer Etiology (EAGLE) study: an integrative population-based case-control study of lung cancer. BMC Public Health. 2008;8:203, doi: 10.1186/1471-2458-8-203.
2. Browning KK, Ferketich AK, Otterson GA, Reynolds NR, Wewers ME. A psychometric analysis of quality of life tools in lung cancer patients who smoke. Lung Cancer. 2009;66:134-9, doi: 10.1016/j.lungcan.2008.12.018.
3. Wan C, Zhang C, Cai L, Tu X, Feng C, Luo J, et al. Psychometric properties of the Chinese version of the FACT-L for measuring quality of life in patients with lung cancer. Lung Cancer. 2007;56: 415-21, doi: 10. 1016/j.lungcan.2007.01.004.
4. Brasil. Ministério da Saú de. Instituto Nacional de Câncer I. Estimativa 2010: Incidência de Câncer no Brasil. Rio de Janeiro: INCA; 2009.
5. Franceschini J, Santos AA, El Mouallem I, Jamnik S, Uehara C, Fernandes AL, et al. [Assessment of the quality of life of patients with lung cancer using the Medical Outcomes Study 36-item Short-Form Health Survey]. J Bras Pneumol. 2008;34:387-93, doi: 10.1590/S1806-37132008000600009.
6. Butt Z, Webster K, Eisenstein AR, Beaumont J, Eton D, Masters GA, et al. Quality of life in lung cancer: the validity and cross-cultural applicability of the Functional Assessment of Cancer Therapy-Lung scale. Hematol Oncol Clin North Am. 2005;19:389-420, viii, doi: 10.1016/j.hoc.2005.02. 009.
7. Cella DF, Bonomi AE, Lloyd SR, Tulsky DS, Kaplan E, Bonomi P. Reliability and validity of the Functional Assessment of Cancer Therapy- Lung (FACT-L) quality of life instrument. Lung Cancer. 1995;12:199-220, doi: 10.1016/0169-5002(95)00450-F.
8. Montazeri A, Gillis CR, McEwen J. Quality of life in patients with lung cancer: a review of literature from 1970 to 1995. Chest. 1998;113:467-81, doi: 10.1378/chest.113.2.467.
9. Webster K, Cella D, Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes. 2003; 1:79, doi: 10.1186/ 1477-7525-1-79.
10. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-98, doi: 10.1016/0022-3956(75)90026-6.
11. Almeida OP. [Mini mental state examination and the diagnosis of dementia in Brazil]. Arq Neuropsiquiatr. 1998;56:605-12.
12. Camelier A, Rosa FW, Salim C, Nascimento OA, Cardoso F, Jardim JR. Using the Saint George's Respiratory Questionnaire to evaluate quality of life in patients with chronic obstructive pulmonary disease: validating a new version for use in Brazil. J Bras Pneumol. 2006;32:114-22, doi: 10. 1590/S1806-37132006000200006.
13. Carpes MF, Mayer AF, Simon KM, Jardim JR, Garrod R. The Brazilian Portuguese version of the London Chest Activity of Daily Living scale for use in patients with chronic obstructive pulmonary disease. J Bras Pneumol. 2008;34:143-51, doi: 10.1590/S1806-37132008000300004.
14. Sousa T, Jardim J, Jones P. Validac ̧ão do Questionário do Hospital Saint George na Doença Respiratória (SGRQ) em pacientes portadores de doença pulmonar obstrutiva crônica no Brasil. J Pneumol. 2000;26:119-28.
15. Kovelis D, Segretti NO, Probst VS, Lareau SC, Brunetto AF, Pitta F. Validation of the Modified Pulmonary Functional Status and Dyspnea Questionnaire and the Medical Research Council scale for use in Brazilian patients with chronic obstructive pulmonary disease. J Bras Pneumol. 2008;34:1008-18.
16. Uehara C, Santoro I, Ferreira R. Câncer de pulmã o: diagnóstico e estadiamento. In: Nery L, Fernandes A, Perfeito J, eds. Pneumologia. Barueri: Manole; 2006. p. 495-509.
17. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest. 1997;111:1710-17, doi: 10.1378/chest.111.6.1710.
18. Karnofsky DA, Golbey RB, Pool JL. Preliminary studies on the natural history of lung cancer. Radiology. 1957;69:477-88.
19. Pereira C. Espirometria. J Pneumol. 2002;28(Suppl. 3):S1-S82.
20. Arnold BJ, Eremenco E, Chang C-H, Odom L, Ribaudo JM, Cella D. Development of a single Portuguese language version of the Functional Assessment of Cancer Therapy - General (FACT-G) Scale. Qual Life Res. 2000;9:316.
21. Arnold BJ, Eremenco S, Chang CH, Cella D, Riberiro JLP, Doro MP et al. How much is "very much"? Developing a rating scale for Portuguese speaking countries. Qual Life Res. 2001; 10:264.
22. Brucker PS, Yost K, Cashy J, Webster K, Cella D. General population and cancer patient norms for the Functional Assessment of Cancer Therapy- General (FACT-G). Eval Health Prof. 2005;28:192-211, doi: 10.1177/ 0163278705275341.
23. Rodriguez-Roisin R, Anzueto A, Bourbeau J, Calverley P, DeGuia T, Fukuchi Y, et al. GOLD - Global Initiative for Chronic Obstructive Pulmonary Disease - Pocket Guide to COPD Diagnoses, Management and Prevention. A Guide for Healthcare Professionals. Medical Communications Resources, Inc.; 2009.
24. Saitoh E, Yokomizo Y, Chang C-H, Eremenco S, Kaneko H, Kobayashi K. Cross-cultural validation of the Japanese version of the lung cancer subscale on the Functional Assessment of Cancer Therapy-Lung. J Nippon Med Sch. 2007;74:402-8, doi: 10.1272/jnms.74.402.
25. Yoo H, Suh C, Kim S, Eremenco S, Kim H, Kim S. Korean translation and validation of the Functional Assessment of Cancer Therapy-Lung (FACT-L) version 4. Qual Life Res. 2006;15:161-6, doi: 10.1007/s11136- 005-8752-x.
26. Cella D, Peterman A, Hudgens S, Webster K, Socinski MA. Measuring the side effects of taxane therapy in oncology: the Functional Assessment of Cancer Therapy-Taxane (FACT-taxane). Cancer. 2003;98:822-31, doi: 10.1002/cncr.11578.
27. Dapueto JJ, Francolino C, Servente L, Chang CH, Gotta I, Levin R, et al. Evaluation of the Functional Assessment of Cancer Therapy-General (FACT-G) Spanish version 4 in South America: classic psychometric and item response theory analyses. Health Qual Life Outcomes. 2003;1:32, doi: 10.1186/1477-7525-1-32.
28. Eton DT, Cella D, Yount SE, Davis KM. Validation of the Functional Assessment of Cancer Therapy-Lung Symptom Index-12 (FLSI-12). Lung Cancer. 2007;57:339-47, doi: 10.1016/j.lungcan.2007.03.021.
29. Hammerschmidt S, Wirtz H. Lung cancer: current diagnosis and treatment. Dtsch Arztebl Int. 2009;106:809-18; quiz 819-20.
30. Young RP, Hopkins RJ, Hay BA, Epton MJ, Mills GD, Black PN, et al. Lung cancer susceptibility model based on age, family history and genetic variants. PLoS One. 2009;4:e5302, doi: 10.1371/journal.pone.0005302.
31. Ozturk A, Sarihan S, Ercan I, Karadag M. Evaluating quality of life and pulmonary function of long-term survivors of non-small cell lung cancer treated with radical or postoperative radiotherapy. Am J Clin Oncol. 2009;32:65-72, doi: 10.1097/COC.0b013e31817e6ec2.
32. Sarna L, Evangelista L, Tashkin D, Padilla G, Holmes C, Brecht ML, et al. Impact of respiratory symptoms and pulmonary function on quality of life of long-term survivors of non-small cell lung cancer. Chest. 2004;125:439-45, doi: 10.1378/chest.125.2.439.